By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Opexa Pharmaceuticals, Inc. 

1709 Dryden Road
Suite 911
Houston  Texas  77030  U.S.A.
Phone: 713-791-9538 Fax: 713-795-4602



Start Up

Company News
Opexa Pharmaceuticals, Inc. Strengthens Patent Portfolio With Expansion Into B-Cell Diseases And Announces Allowance Of 98th T-Cell Patent 9/29/2014 11:33:01 AM
Opexa Pharmaceuticals, Inc. Announces News Release And Conference Call Schedule To Discuss Second Quarter 2014 Financial Results 8/11/2014 8:39:04 AM
Opexa Pharmaceuticals, Inc. to Present at the Rodman & Renshaw 15th Annual Global Investment Conference 9/5/2013 8:42:42 AM
Opexa Pharmaceuticals, Inc. to Present at the Oppenheimer 22nd Annual Healthcare Conference 12/9/2011 6:46:14 AM
Opexa Pharmaceuticals, Inc. Executes Strategic Service Agreement with the American Red Cross 5/17/2011 10:29:22 AM
Opexa Pharmaceuticals, Inc. to Participate in Panel Discussion on Personalized Medicine for Multiple Sclerosis 4/1/2010 10:41:16 AM
Seasoned Clinical Development Expert Joins Opexa Pharmaceuticals, Inc. to Lead Tovaxin(R) Development in Multiple Sclerosis 12/2/2009 9:26:14 AM
Opexa Pharmaceuticals, Inc. Regains NASDAQ Compliance Following Stem Cell Agreement 8/10/2009 9:43:02 AM
Opexa Pharmaceuticals, Inc. Reports First Quarter 2008 Financial Results and Updates on Tovaxin(R) Phase IIb Study 5/14/2008 8:49:25 AM
Opexa Pharmaceuticals, Inc. Presents Tovaxin Phase I/II Data at the American Academy of Neurology 60th Annual Meeting 4/16/2008 9:25:26 AM